Healthcare Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
Production and Market of Analgin in China in 2015

Production and Market of Analgin in China in 2015

Date Published: Jul 29 2015

1.INTRODUCTION

In this report, ASKCI analyzes the market size of analgin, supply and demand of analgin, major analgin production, import and export situation, consumption situation by downstream industry, etc. as well as make scientific prediction on the future development analgin industry.
 

The Aim of this report

$3,500.00
Croatia Pharmaceuticals and Healthcare Report Q4 2015

Croatia Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Jul 29 2015

BMI View: The Croatian Health Insurance Fund (HZZO)'s independence will enable it to further
rationalise its healthcare expenditure without political interference. We see the HZZO utilising its
purchasing power to drive down drug prices from pharmaceutical companies in return for wider
reimbursement coverage. As a result, pharmaceutical sales growth in Croatia will be moderated over the
medium-term, with negative implications for multinational drugmakers.
Headline Expenditure Projections

$1,295.00
Gabon Pharmaceuticals and Healthcare Report Q4 2015

Gabon Pharmaceuticals and Healthcare Report Q4 2015

Date Published: Jul 29 2015

BMI View: Gabon will become one of the first Sub-Saharan African countries where the burden of noncommunicable
diseases will exceed that of communicable diseases. The country's oil revenues have resulted
in high relative wealth levels, and a greater prevalence of non-communicable diseases such as diabetes and
cancer.
Headline Expenditure Forecasts
■ Pharmaceuticals: XAF46.20bn (USD94mn) in 2014 to XAF48.14bn (USD81mn) in 2015; +4.2% in
local currency and -14.5% in US dollar terms. Forecast downgraded from Q315 following availability of

$1,295.00
Development and Market of Ophthalmic Hospital in China

Development and Market of Ophthalmic Hospital in China

Date Published: Jul 24 2015

1. INTRODUCTION

In China, basically, ophthalmic medical services provided by comprehensive hospitals and specialized hospitals. In 2011, over 66 million patients visited comprehensive hospitals and specialized hospitals for ophthalmic treatment. 89.26% of patients visited comprehensive hospitals, and 10.74% were specialized hospital patients. 
 
$3,500.00
Kuwait Pharmaceuticals and Healthcare Report Q3 2015

Kuwait Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 22 2015
$1,295.00
Development and Market of Da Vinci Surgical System in Globe and China

Development and Market of Da Vinci Surgical System in Globe and China

Date Published: Jul 22 2015

1. INTRODUCTION

Recent years, surgical robots have wide application in minimally invasive surgery. Da Vinci Surgical System mainly apply to urology surgery, general surgery, cardiac surgery, gynecological surgery, and thoracic surgery; in global records, it applied in gynecological surgery most often.
 
$3,500.00
Development and Market of Medical Composite Membrane in China

Development and Market of Medical Composite Membrane in China

Date Published: Jul 22 2015

1. INTRODUCTION

Medical composite membrane mainly apply to medicine manufacturing industry, its development has positive correlation with medicine manufacturing industry development. As Chinese raised expense on public medical service system, for satisfying the demand of downstream medicine manufacturing industry, medical composite membrane industry invested more funds on technology research, in order to accelerate industry development. 
 
$3,500.00
Market Analysis of Women and Children’s Hospital in China 2015-2020

Market Analysis of Women and Children’s Hospital in China 2015-2020

Date Published: Jul 21 2015

1. INTRODUCTION

In recent years, with the support of the government, women and children’s healthcare has made great progress. The mortality rates of pregnant women, new born babies and children under 5 years old have decreased significantly. 
 
By 2011, there were 3557 women and children’s hospitals in China. However, the demand of the market outnumbers the supply and more doctors in this specialty are needed. Favorable policies have been carried out by government as well. 
$3,500.00
eHealth: Applications and Major Vendors' Patent Deployment

eHealth: Applications and Major Vendors' Patent Deployment

Date Published: Jul 20 2015
In the face of an aging population and the rise of chronic diseases, governments around the world have been looking for solutions to reducing health care expenditures while maintaining medical service quality. eHealth, which provides electronic, digital, and automated medical services, is one of such solutions. This report provides an overview of eHealth applications and examines the relative R&D intensity and patent deployments of several established players in the industry, including Bosch, Medtronic, General Electric, Philips, Siemens, and Honeywell.
$2,000.00
Company Profile of Top 50 Suppliers for Health Care and Nutrition Product in 2014

Company Profile of Top 50 Suppliers for Health Care and Nutrition Product in 2014

Date Published: Jul 16 2015

1.INTRODUCTION

With the improving of living standard, people pay more attention on health care. Owing to this, the market size of China’s health care and nutrition industry has increased sharply, with an annual growth rate over 25% in recent decade. In 2014, the output value of health care and nutrition industry reached RMB180 billion, with a YoY of 30%. According to China Food and Drug Administration, there are 15,797 health care products as of July 2015, including 15,058 domestic made products and 739 imported ones.
$6,500.00
Portugal Pharmaceuticals and Healthcare Report Q3 2015

Portugal Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 15 2015
Despite the registered recovery in Portugal's economic indicators in recent quarters, substantial risks will remain to pharmaceutical firms that sell drugs in the country, especially due to delays in payments by public hospitals and high levels of public and private debt. The registered improvements in domestic demand, pharmaceutical exports and manufacturing indices will be partially counterbalanced by the slow progress in structural reforms to enhance competitiveness, offering a mixed outlook over the medium-term.
 
$1,295.00
Switzerland Pharmaceuticals and Healthcare Report Q3 2015

Switzerland Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 15 2015
The preference for patented drugs over low-value generic medicines by patients and prescribers in Switzerland will drive the government to continue to enforce measures that restrict growth in innovative medicine sales - particularly as the ageing population will boost the demand for long-term medicines. This will include price cuts on patented medicines as well as a push towards the greater promotion of lowervalue generic medicines.
 

Headline Expenditure Projections 

$1,295.00
Vietnam Pharmaceuticals and Healthcare Report Q3 2015

Vietnam Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 15 2015
Counterfeit and substandard medicines will remain highly pervasive in Vietnam's pharmaceutical market. While this reflects the limited capacity of regulators to address the problem, its persistence also illustrates the presence of a sizeable market for manufacturers of counterfeit and low quality medicines. We highlight that pharmaceutical products most affected by this practice are small molecule medicines.
 

Headline Expenditure Projections 

$1,295.00
Ghana Pharmaceuticals and Healthcare Report Q3 2015

Ghana Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 15 2015
Our growth outlook for Ghana's pharmaceutical expenditure is positive, and will be driven by expanding NHIS coverage and improving public healthcare provision. Further reforms to Ghana's National Health Insurance Scheme (NHIS) will allow the scheme's continuation, improving the population's access to healthcare - as will the rise in healthcare infrastructure.
 

Headline Expenditure Projections

$1,295.00
Mauritius Pharmaceuticals and Healthcare Report Q3 2015

Mauritius Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 15 2015
While population size is low in comparison to other African countries, Mauritius' per capita pharmaceutical spending is higher than any other in the region. With the government showing great interest in universal health coverage and health system sustainability, the ageing population of Mauritius will become an attractive target for pharmaceutical and healthcare providers.
 

Headline Expenditure Projections

$1,295.00
Chile Pharmaceuticals and Healthcare Report Q3 2015

Chile Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 8 2015
$1,295.00
Egypt Pharmaceuticals and Healthcare Report Q3 2015

Egypt Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 8 2015
The positive outlook for Egypt's pharmaceutical market has been reinforced, with access to medicines increasing through enhancing health insurance uptake and a greater interest among foreign pharmaceutical companies. This represents an impressive turnaround, given the region's political instability in recent years.
 

Headline Expenditure Projections 

$1,295.00
Greece Pharmaceuticals and Healthcare Report Q3 2015

Greece Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 8 2015
$1,295.00
Iraq Pharmaceuticals and Healthcare Report Q3 2015

Iraq Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 8 2015
Iraq's pharmaceutical market will remain an unattractive proposition for multinational drugmakers in the short-term at least. Lower oil prices and the presence of Islamic State will subdue government finances, and the cutting of subsidies will negatively impact consumer purchasing power, both feeding in to a subdued outlook for pharmaceutical consumption.
 

Headline Expenditure Projections 

$1,295.00
Malaysia Pharmaceuticals and Healthcare Report Q3 2015

Malaysia Pharmaceuticals and Healthcare Report Q3 2015

Date Published: Jul 8 2015
$1,295.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data